We are a biopharmaceutical company dedicated to developing innovative solutions for pain management. Our focus is on the discovery and development of a novel, safer class of analgesics through the use of transmembrane allosteric modulation of the mu opioid receptor. Our goal is to bring a new level of safety and efficacy to patients suffering from chronic pain, reducing dependence and adverse effects associated with traditional opioids. With our cutting-edge research and dedication to improving patient lives, we aim to revolutionize the pain management industry.
Company Details
- Founded
- 2021
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- hyperexponential.
Mu42 Questions
Mu42's LinkedIn profile is https://www.linkedin.com/company/mu42pl
Mu42's industry is
Biotechnology Research
Mu42's top competitors are
Tango Therapeutics,
Project42,
Tayseer Finance - التيسير للتمويل,
Zen.com,
P42med,
Hyperexponential,
Unbound Potential.
Mu42's categories are Biotechnology Research
Mu42's founding year is 2021
